88454877 - PRELUDE THERAPEUTICS

Information

  • Trademark
  • 88454877
  • Serial Number
    88454877
  • Registration Number
    6918641
  • Filing Date
    May 31, 2019
    5 years ago
  • Registration Date
    December 06, 2022
    a year ago
  • Transaction Date
    April 12, 2023
    a year ago
  • Status Date
    December 06, 2022
    a year ago
  • Published for Opposition Date
    March 15, 2022
    2 years ago
  • Location Date
    October 31, 2022
    a year ago
  • First Use Anywhere Date
    April 20, 2017
    7 years ago
  • First Use In Commerce Date
    April 20, 2017
    7 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DEFORD, JEFFREY S
  • Attorney Docket Number
    105807.00502
    Attorney Name
    Lisa Bollinger Gehman
    Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
3000
Mark Identification
PRELUDE THERAPEUTICS
Case File Statements
  • DM0000: The mark consists of a series of DNA strands formed into an eight-pointed star shaped design, to the right of the design appears the word "PRELUDE" having the first letter capitalized and the word "THERAPEUTICS" in smaller capital block letters centered below "PRELUDE.".
  • CC0000: Color is not claimed as a feature of the mark.
  • D10000: "THERAPEUTICS"
  • GS0421: Research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research for medical purposes in the fields of oncology, hematology, autoimmune diseases, and rare diseases; clinical research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer, hematological diseases, autoimmune diseases, and rare diseases; providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; genetic testing for scientific research; genetic research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; none of the foregoing in relation to or in the field of fertility
Case File Event Statements
  • 12/6/2022 - a year ago
    36 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/6/2022 - a year ago
    35 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/1/2022 - a year ago
    34 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 10/31/2022 - a year ago
    33 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 10/12/2022 - a year ago
    32 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 9/29/2022 - a year ago
    31 - USE AMENDMENT FILED Type: IUAF
  • 10/12/2022 - a year ago
    30 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 9/29/2022 - a year ago
    29 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 5/10/2022 - 2 years ago
    28 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 3/15/2022 - 2 years ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/15/2022 - 2 years ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/23/2022 - 2 years ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/6/2022 - 2 years ago
    24 - ASSIGNED TO LIE Type: ALIE
  • 2/4/2022 - 2 years ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/3/2022 - 2 years ago
    22 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/2/2022 - 2 years ago
    21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/2/2022 - 2 years ago
    20 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 8/18/2021 - 2 years ago
    19 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 8/18/2021 - 2 years ago
    18 - FINAL REFUSAL E-MAILED Type: GNFR
  • 8/18/2021 - 2 years ago
    17 - FINAL REFUSAL WRITTEN Type: CNFR
  • 1/14/2021 - 3 years ago
    16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 6/24/2020 - 4 years ago
    15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 12/20/2019 - 4 years ago
    14 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/20/2019 - 4 years ago
    13 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/20/2019 - 4 years ago
    12 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/4/2019 - 4 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/3/2019 - 4 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/3/2019 - 4 years ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/23/2019 - 4 years ago
    8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/23/2019 - 4 years ago
    7 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/23/2019 - 4 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/21/2019 - 4 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/24/2019 - 5 years ago
    4 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/18/2019 - 5 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/15/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/4/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP